$ADMP Pre-market: 6.45 +0.70 (+12.17%) FDA approval Adamis Pharma stock skyrockets after rival EpiPen product gets FDA approval http://www.marketwatch.com/story/adamis-pharma-stock-skyrockets-after-rival-epipen-product-gets-fda-approval-2017-06-15